Louisville Metabolic and Atherosclerosis Research Center

Louisville, Kentucky 40213

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
Louisville Metabolic and Atherosclerosis Research Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling, Phase II
Updated: 8/21/2015
Louisville Metabolic and Atherosclerosis Research Center
mi
from
Louisville, KY
Click here to add this to my saved trials